No Data
No Data
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)
Toronto, Ontario--(Newsfile Corp. - Le 19 mars/March 2024) - PanGenomic Health Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry
PanGenomic Health (NARA.CSE) on Wednesday announced that its subsidiary, MUJN Diagnostics Inc., has introduced its point-of-care Vitamin D test for the dental implant industry. Current clinical resea
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - November 22, 2023) - Investorideas.com (www.investorideas.com), a global investor news source covering health and wellness stocks rele
PanGenomic Health Announces Director Resignations
PanGenomic Health Inc. (CSE: NARA) announced today that independent directors, Peter Green and Jonathan Lutz, tendered their resignations effective as of July 12, 2023.
PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments
PanGenomic Health Inc. (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. , has commenced a Vitamin D health assessment service and has also launched a corporate website at mujn.ai.
Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc.
VANCOUVER, BC, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transfo